This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) reachead $119.72 at the closing of the latest trading day, reflecting a -0.52% change compared to its last close.
Is the Options Market Predicting a Spike in Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Tenet (THC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Tenet Healthcare (THC) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $133.40 in the latest trading session, marking a -0.82% move from the prior day.
Community Health Rides on Same-Store Volumes, Streamlining Efforts
by Zacks Equity Research
With improving labor trends, CYH's contract labor expenses are decreasing.
Universal Health Services (UHS) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tenet Healthcare Gains 26.9% in a Year: Is It the Right Time to Invest?
by Zacks Equity Research
THC benefits from rising admissions, improved payer mix and deleveraging initiatives.
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the most recent trading session, Tenet Healthcare (THC) closed at $133.04, indicating a +1.73% shift from the previous trading day.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $130.78, denoting a +1% change from the preceding trading day.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $127.75, denoting a +1.93% change from the preceding trading day.
Universal Health Stock Down 26.6% in 6 Months: Should You Buy the Dip?
by Zacks Equity Research
UHS' rising admissions and patient days poise its top line well for growth in the future.
Tenet (THC) Down 10.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
EHC Gains on Sustained Revenue Growth, Expansion Plans
by Zacks Equity Research
Encompass Health benefits from strong patient volumes, continued expansion endeavors across the United States and a robust 2025 business outlook.
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $119.51, representing a -1.39% change from its previous close.
Tenet Healthcare (THC) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $125.44 in the latest trading session, marking a -0.46% move from the prior day.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
by Zacks Equity Research
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare's Cheaper Valuation: A Hidden Gem in Healthcare?
by Kaibalya Pravo Dey
THC is strengthening its focus on ASCs to tap into the growing demand for outpatient services.
Tenet (THC) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
5 Top-Ranked Stocks Poised for an Earnings Beat
by Sanghamitra Saha
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.